Aesthetic distributor Aesthetic Medical Partnership (AMP) has taken over UK and Ireland distribution of Cellenis platelet-rich plasma (PRP).
AMP explains that Cellenis PRP uses a medical-grade separation device designed to process 11 and 22ml blood, utilising a separator gel to minimise granulocytes and erythrocytes (red blood cells) from the PRP before treatment.
The distribution partnership also includes Cellenis PRP DermaFiller – a regenerative volumising product which is due to be released in the UK in the coming months.
AMP co-founder and director Martyn Roe said, “We are delighted to grow the Cellenis brand in the UK. Cellenis PRP is the number one PRP provider in the US, and we look forward to adding Cellenis customers to our growing list of AMP partners. To further develop our focus on regenerative medicine, we are particularly excited to launch Cellenis PRP DermaFiller, a fully autologous regenerative volumiser, in the UK market in the next few months.”
tribute Cellenis PRP